EFFICACY AND SAFETY OF ORMELOXIFENE IN REGRESSION OF MASTALGIA ASSOCIATED WITH FIBROCYSTIC DISEASE OF BREAST.

Journal Title: IJSR-International Journal Of Scientific Research - Year 2017, Vol 6, Issue 8

Abstract

Background: Mastalgia and brocystic breast disease is common occurance in women of reproductive age group.. Ormeloxifene is a weak oestrogen receptor (ER) agonist, a strong ER antagonist (SERA) and therefore a selective ER modulator (SERM)used in the treatment of the disease. Aim of study was to see the efcacy and safety of Ormeloxifene in regression of mastalgia associated with brocystic breast disease. Material and method- This was prospective trial, conducted in NMCH ,Patna from November 2015 to March 2017.. Fifty women of age 20-40 year with mastalgia associated with brocyctic disease of breast with VAS score more than 2 were treated with Ormeloxifene 30mg once daily on alternate days for a period of 3 months . Follow up was done monthly for 3 month and then at 6 month with Visual Analogue Scale (VAS) for pain and for side effect. Results-Total 63 patients were enrolled in the study. 13 patients left during trial . 50 patients completed the trial.The mean age was 34 year. The mean pain level was continuously decreased over 5 visit (4.72to 0.84) at 24 week.15(30%)patients reported oligomenorrhoea. Conclusion: Ormeloxifene showed signicant efcacy and safety for the treatment of mastalgia in brocystic breast disease.

Authors and Affiliations

Dr . Aashita Shrivastava

Keywords

Related Articles

FETUS IN FETU

Fetus-in-fetu (FIF) is an uncommon pathology with an incidence of 1 in 500000 births. Less than 200 cases have been reported worldwide. Multiple theories are proposed regarding embryogenesis 1,2. The anomaly can be anten...

Research Into Epidemiological Factors for Hanging as a Method of Suicide

Background: Although it is said that hanging is a form of violent asphyxial death but it produces painless death. All the material needed is present in home, so can be carried out privately in home. So it is a widely use...

RISK STRATIFICATION USING APPENDICITIS INFLAMMATORY RESPONSE SCORE, A USEFUL TOOL TO REDUCE NEGATIVE APPENDICECTOMY RATE : OUR EXPERIENCE

Background: Acute appendicitis is mostly considered a clinical diagnosis and many surgeons resort to clinical judgement for deciding its management. Such cases often pose a diagnostic dilemma and result in significant ne...

CYTOLOGIC DIAGNOSIS OF PARASITES PRESENTING AS CYSTIC LESIONS

Parasitic infections often present as supercial as well as visceral cysts. Fine needle aspiration cytology (FNAC) and Exfoliative cytology are very useful tool to visualise these parasites. Both conventional and liquid...

PAGET-SCHROETTER SYNDROME A.K.A. EFFORT THROMBOSIS (UPPER EXTREMITY DEEP VEIN THROMBOSIS)

Deep vein thrombosis according to etiology classified into primary or secondary and according to location upper limb DVT and lower limb DVT. Incidence of secondary DVT are high and seen mostly in hospitalized patient eti...

Download PDF file
  • EP ID EP511183
  • DOI -
  • Views 70
  • Downloads 0

How To Cite

Dr . Aashita Shrivastava (2017). EFFICACY AND SAFETY OF ORMELOXIFENE IN REGRESSION OF MASTALGIA ASSOCIATED WITH FIBROCYSTIC DISEASE OF BREAST.. IJSR-International Journal Of Scientific Research, 6(8), 1-2. https://europub.co.uk./articles/-A-511183